| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/14/2002 | WO2002021142A1 Method of quantifying total hemoglobin and glycohemoglobin |
| 03/14/2002 | WO2002021140A1 Nucleic acid sequences and proteins involved in cellular senescence |
| 03/14/2002 | WO2002021139A2 Automated identification of peptides |
| 03/14/2002 | WO2002021138A2 The m30 gene family and the utilization thereof |
| 03/14/2002 | WO2002021137A1 Method for identifying cell-specific proteins |
| 03/14/2002 | WO2002021136A2 Method for quantitatively determining the available binding capacity in an aqueous protein solution |
| 03/14/2002 | WO2002021135A2 Rapid screen to identify p-glycoprotein substrates and high-affinity modulators |
| 03/14/2002 | WO2002021134A2 Methods of diagnosing breast cancer and screening for modulators |
| 03/14/2002 | WO2002021133A2 Methods of detecting cancer based on prostasin |
| 03/14/2002 | WO2002021132A2 Cell assays |
| 03/14/2002 | WO2002021130A2 Method and device for simultaneous detection of multiple components in a mixture |
| 03/14/2002 | WO2002021129A1 Method of monitoring the effect of cathepsin s inhibitors |
| 03/14/2002 | WO2002021128A2 Cellular arrays comprising encoded cells |
| 03/14/2002 | WO2002021127A2 Method for analysing the ageing of the skin |
| 03/14/2002 | WO2002021125A2 Drug discover employing calorimetric target triage |
| 03/14/2002 | WO2002021124A1 Method of measuring inherent clearance, binding ratio to serum protein and organ clearalnce of drug |
| 03/14/2002 | WO2002021123A1 Improvements in instruments for measuring the total organic carbon content of water |
| 03/14/2002 | WO2002021115A1 Method for producing a 3-d micro flow cell and a 3-d micro flow cell |
| 03/14/2002 | WO2002021114A1 Method of detecting gas with the use of photocurrent amplification and the like and gas sensor |
| 03/14/2002 | WO2002021102A2 Particle or cell analyzer and method |
| 03/14/2002 | WO2002021101A1 Method for determining taste and/or smell in liquid or solid products |
| 03/14/2002 | WO2002021083A1 Robust fluid flow and property microsensor made of optimal material |
| 03/14/2002 | WO2002020848A2 Gene and sequence variation associated with cancer |
| 03/14/2002 | WO2002020847A2 Gene and sequence variation associated with lipid disorder |
| 03/14/2002 | WO2002020846A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 03/14/2002 | WO2002020842A1 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 03/14/2002 | WO2002020841A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment |
| 03/14/2002 | WO2002020839A1 Method of determining base sequence |
| 03/14/2002 | WO2002020838A2 Method and system for detecting nucleic acids |
| 03/14/2002 | WO2002020837A2 Method of nucleic acid typing or sequencing |
| 03/14/2002 | WO2002020834A2 Method for the identification of genes that are involved in the modulation of a poptosis in cells |
| 03/14/2002 | WO2002020833A2 Method for the specific determination of dna -sequences by means of parallel amplification |
| 03/14/2002 | WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | WO2002020825A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
| 03/14/2002 | WO2002020823A2 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020770A1 Method of screening antitumor agent by using interaction between arf protein and hk33 protein |
| 03/14/2002 | WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020759A2 A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
| 03/14/2002 | WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020740A2 Proteolysis targeting chimeric pharmaceutical |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020718A2 Osteoclast-associated receptor |
| 03/14/2002 | WO2002020670A1 Oxazine derivatives |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020570A2 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020555A2 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 03/14/2002 | WO2002020554A2 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 03/14/2002 | WO2002020514A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | WO2002020492A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| 03/14/2002 | WO2002020469A1 Substrate with controlled amine density and regular spacing and method for preparing the same |
| 03/14/2002 | WO2002020464A2 Benzene tricarboxylic acid amides as insulin receptor activators |
| 03/14/2002 | WO2002020435A2 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 03/14/2002 | WO2002020416A2 Polyhydroxyalkanoate levels as an indicator of bioreactor health |
| 03/14/2002 | WO2002020179A2 Modified carbon, silicon and germanium surfaces |
| 03/14/2002 | WO2002020160A1 Description |
| 03/14/2002 | WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | WO2002020054A2 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy |
| 03/14/2002 | WO2002020049A2 Eiav chimeric vaccine and diagnostic |
| 03/14/2002 | WO2002020043A1 Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator |
| 03/14/2002 | WO2002020036A1 Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter |
| 03/14/2002 | WO2002020032A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/14/2002 | WO2002020003A2 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | WO2002019904A1 Monitoring of total ammoniacal concentration in blood |
| 03/14/2002 | WO2002019894A2 Methods for analyzing and using data from hypertensive patients |
| 03/14/2002 | WO2002019812A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 03/14/2002 | WO2001091634A3 Apparatus and method for obtaining blood for diagnostic tests |
| 03/14/2002 | WO2001090731A3 Processing chamber with apertures for pipette access |
| 03/14/2002 | WO2001090189A3 G-protein coupled receptor org3. |
| 03/14/2002 | WO2001085981A3 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 03/14/2002 | WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 03/14/2002 | WO2001080718A3 Methods and compositions for the diagnosis of schizophrenia |
| 03/14/2002 | WO2001080712A3 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease |
| 03/14/2002 | WO2001077147A3 New bromodomain protein |
| 03/14/2002 | WO2001075433A3 Capillary flow control in a fluidic diagnostic device |
| 03/14/2002 | WO2001071355A3 Igf-i, igfbp-3 and psa in prostate cancer prediction |
| 03/14/2002 | WO2001070768A3 Receptor-binding compounds and method for identifying them |
| 03/14/2002 | WO2001069200A3 Methods for detection of differences in nucleic acids |
| 03/14/2002 | WO2001068836A3 Methods and compositions for rna interference |
| 03/14/2002 | WO2001068238A3 Microfluidic analysis cartridge |
| 03/14/2002 | WO2001066227A3 Method and device for quickly and continually detecting changes in the concentration of radon gas that is dissolved in water |
| 03/14/2002 | WO2001063286A3 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 03/14/2002 | WO2001063245A3 Method and apparatus for high throughput cell - based assays for screening and diagnostics |
| 03/14/2002 | WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof |
| 03/14/2002 | WO2001062688A3 Methods of structure-based drug design using ms/nmr |
| 03/14/2002 | WO2001062377A3 Microarray fabrication techniques and apparatus |
| 03/14/2002 | WO2001061053A3 Protein and peptide sensors using electrical detection methods |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001059476A3 Sample preparation method |
| 03/14/2002 | WO2001059446A3 Assay for detecting change in membrane potential |